In July 2020, Cogstate Ltd. (US) partnered with ERT (a part of Clario Tech DMCC), a leader in clinical endpoint data collection, to expand its industry-leading eCOA solution with digital cognitive endpoints from Cogstate to support the development of treatments for CNS and other disorders.
Northbrook, IL 60062 -- (SBWIRE) -- 06/13/2022 -- According to the new market research report "Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) - Global Forecast to 2026", published by MarketsandMarkets™, the global Memory Enhancement Market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period.
Browse in-depth TOC on "Cognition and Memory Enhancement Market"
7 – Tables
3 – Figures
25 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23532463
The Growing adoption of nutraceuticals for cognitive health is among the primary factors that drive the market growth. To achieve a better quality of life and cognitive health, consumers of all ages have started including more vegetables, fruits, dietary supplements, probiotics, prebiotics, phytotherapeutic substances, and other plant foods in their diets. Consequently, there has been an increase in the demand for nutraceutical ingredients over the past few years, as they are being used by consumers for various health benefits
The cognition & memory-enhancing drugs segment accounted for the largest share of the cognition enhancement market in 2020.
On the basis of product & service, the memory enhancement market is segmented into cognition & memory-enhancing drugs, brain-boosting nutraceuticals, and cognitive assessment & training solutions. In 2020, the cognition & memory-enhancing drugs segment accounted for the largest segment of the cognition and memory enhancement market. The large share of this segment can primarily be attributed to the increasing R&D by leading pharmaceutical companies in dementia-related diseases such as Alzheimer's.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=23532463
The Asia Pacific region is the fastest-growing region of the cognition enhancement market in 2020.
The memory enhancement market in the Asia Pacific region is projected to register the highest growth during the forecast period. Growing prevalence of neurological disorders in this region is a major factors driving the growth of the Asia Pacific market.
Some of the leading players operating in the cognition enhancement market include Eisai Co., Ltd. (Japan), Johnson & Johnson Services, Inc. (US), Biogen Inc. (US), Eli Lilly and Company (US), Nordic Naturals (US), Natrol, LLC (US), Cambridge Cognition Ltd. (UK), and Cogstate Ltd. (US).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=23532463